- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Joined Cases C-101/19 and C-102/19: Judgment of the Court (Eighth Chamber) of 23 April 2020 (requests for a preliminary ruling from the Bundesverwaltungsgericht — Germany) — Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG v Bundesrepublik Deutschland (References for a preliminary ruling — Medicinal products for human use — Directive 2001/83/EC — Articles 62 and 69 — Particulars on the labelling and package leaflet of homeopathic medicinal products — Exhaustive list of the particulars or possibility to add information that is useful to the patient and is compatible with the summary of product characteristics — Dosage schedules for homeopathic medicinal products)
ECLI:EU:UNKNOWN:62019CA0101
62019CA0101
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
13.7.2020
Official Journal of the European Union
C 230/10
(Joined Cases C-101/19 and C-102/19) (*)
(References for a preliminary ruling - Medicinal products for human use - Directive 2001/83/EC - Articles 62 and 69 - Particulars on the labelling and package leaflet of homeopathic medicinal products - Exhaustive list of the particulars or possibility to add information that is useful to the patient and is compatible with the summary of product characteristics - Dosage schedules for homeopathic medicinal products)
(2020/C 230/13)
Language of the case: German
Referring court
Parties to the main proceedings
Applicant, appellant and appellant on a point of law: Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG
Defendant, respondent and respondent in the appeal on a point of law: Bundesrepublik Deutschland
Operative part of the judgment
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, as modified by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, must be interpreted as precluding the package leaflet referred to in Article 69 thereof from including information other than that listed in that provision, in particular dosage schedules for homeopathic medicinal products covered by that provision.
(*)
Language of the case: German
* * *
(1) OJ C 172, 20.5.2019.